Exploration of the in vitro Antiviral Effects and the Active Components of Changyanning Tablets Against Enterovirus 71

References

• Sun J, Li Y, Yang Z, Fang Q, Chen B. Effect of enterovirus 71 vaccination on the epidemiological characteristics and etiology in hospitalized children with hand-foot-and-mouth disease: a retrospective study from a tertiary children’s hospital. Medicine. 2022;101(37):e30356. doi:10.1097/MD.0000000000030356
   PubMed Web of Science ®Google Scholar
• Nguyet LA, Thanh TT, Nhan LNT, et al. Neutralizing antibodies against enteroviruses in patients with hand, foot and mouth disease. Emerg Infect Dis. 2020;26(2):298–306. doi:10.3201/eid2602.190721
   PubMed Web of Science ®Google Scholar
• Liang ZL, Mao QY, Wang YP, et al. Progress on the research and development of inactivated EV71 whole-virus vaccines. Hum Vaccin Immunother. 2013;9(8):1701–1705. doi:10.4161/hv.24949
   PubMed Web of Science ®Google Scholar
• Saguil A, Kane S, Lauters R, Mercado M. Hand-foot-and-mouth disease: rapid evidence review. Am Family Phys. 2019;100(7):408–414.
   PubMed Web of Science ®Google Scholar
• Zhang W, Huang Z, Huang M, Zeng J. Predicting severe enterovirus 71-infected hand, foot, and mouth disease: cytokines and Chemokines. Mediators Inflamm. 2020;2020:9273241. doi:10.1155/2020/9273241
   PubMed Web of Science ®Google Scholar
• Esposito S, Principi N. Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention. Eur J Clin Microbiol Infect Dis. 2018;37(3):391–398. doi:10.1007/s10096-018-3206-x
   PubMed Web of Science ®Google Scholar
• Mao QY, Wang Y, Bian L, Xu M, Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Expert Rev Vaccines. 2016;15(5):599–606. doi:10.1586/14760584.2016.1138862
   PubMed Web of Science ®Google Scholar
• Du Z, Huang Y, Bloom MS, et al. Assessing the vaccine effectiveness for hand, foot, and mouth disease in Guangzhou, China: a time-series analysis. Hum Vaccin Immunother. 2021;17(1):217–223. doi:10.1080/21645515.2020.1763076
   PubMed Web of Science ®Google Scholar
• Li J, Yin X, Lin A, et al. EV71 vaccination impact on the incidence of encephalitis in patients with hand, foot and mouth disease. Hum Vaccines Immunother. 2021;17(7):2097–2100. doi:10.1080/21645515.2020.1851129
   PubMed Web of Science ®Google Scholar
• Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10(11):778–790. doi:10.1016/S1473-3099(10)70194-8
   PubMed Web of Science ®Google Scholar
• Huang K, Zhang P, Zhang Z, et al. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: efficacies and mechanisms. Pharmacol Ther. 2021;225:107843. doi:10.1016/j.pharmthera.2021.107843
   PubMed Web of Science ®Google Scholar
• Tang J, Zhang G, Xing J, Yu Y, Han T. Network meta-analysis of heat-clearing and detoxifying oral liquid of Chinese medicines in treatment of children’s hand-foot-mouth disease: a protocol for systematic review and meta-analysis. Medicine. 2022;101(5):e28778. doi:10.1097/MD.0000000000028778
   PubMed Web of Science ®Google Scholar
• Li XH, Li SJ, Xu Y, et al. Effect of integrated Chinese and Western medicine therapy on severe hand, foot and mouth disease: a prospective, randomized, controlled trial. Chin J Integr Med. 2017;23(12):887–892. doi:10.1007/s11655-016-2504-3
   PubMed Web of Science ®Google Scholar
• Yu W, Zhang Y, Kang C, et al. The pharmacological evidence of the Chang-yan-ning formula in the treatment of colitis. Front Pharmacol. 2022;13:1029088. doi:10.3389/fphar.2022.1029088
   PubMed Web of Science ®Google Scholar
• Hu X, Yang F. Analysis of the therapeutic effect of changyanning on intestinal flora in inflammatory bowel disease. Contrast Media Mol Imaging. 2022;2022:3757763. doi:10.1155/2022/3757763
   PubMed Web of Science ®Google Scholar
• Guo P, Wang Z, Lv X, et al. Changyanning regulates gut microbiota and metabolism to ameliorate intestinal injury induced by ETEC K88. Front Microbiol. 2023;14:1098818. doi:10.3389/fmicb.2023.1098818
   PubMed Web of Science ®Google Scholar
• Kang N, Gao H, He L, et al. Ginsenoside Rb1 is an immune-stimulatory agent with antiviral activity against enterovirus 71. J Ethnopharmacol. 2021;266:113401. doi:10.1016/j.jep.2020.113401
   PubMed Web of Science ®Google Scholar
• Yu Y, Yao C, Guo DA. Insight into chemical basis of traditional Chinese medicine based on the state-of-the-art techniques of liquid chromatography-mass spectrometry. Acta Pharm Sin B. 2021;11(6):1469–1492. doi:10.1016/j.apsb.2021.02.017
   PubMed Web of Science ®Google Scholar
• Chen K, Liu J, Ma Z, Duan F, Guo Z, Xiao H. Rapid identification of chemical constituents of Rhodiola crenulata using liquid chromatography-mass spectrometry pseudotargeted analysis. J Sep Sci. 2021;44(20):3747–3776. doi:10.1002/jssc.202100342
   PubMed Web of Science ®Google Scholar
• Yuan Z, Pan Y, Leng T, et al. Progress and prospects of research ideas and methods in the network pharmacology of Traditional Chinese Medicine. J Pharm Pharm Sci. 2022;25:218–226. doi:10.18433/jpps32911
   PubMed Web of Science ®Google Scholar
• Liu YY, Yu LH, Zhang J, Xie DJ, Zhang XX, Yu JM. Network pharmacology-based and molecular docking-based analysis of suanzaoren decoction for the treatment of parkinson’s disease with sleep disorder. Biomed Res Int. 2021;2021:1752570. doi:10.1155/2021/1752570
   PubMed Web of Science ®Google Scholar
• Liu J, Liu J, Tong X, et al. Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of huai hua san against ulcerative colitis. Drug Des Devel Ther. 2021;15:3255–3276. doi:10.2147/DDDT.S319786
   PubMed Web of Science ®Google Scholar
• Crampon K, Giorkallos A, Deldossi M, Baud S, Steffenel LA. Machine-learning methods for ligand-protein molecular docking. Drug Discov Today. 2022;27(1):151–164. doi:10.1016/j.drudis.2021.09.007
   PubMed Web of Science ®Google Scholar
• Das DR, Kumar D, Kumar P, Dash BP. Molecular docking and its application in search of antisickling agent from Carica papaya. J Appl Biol Biotech. 2020;8(01):105–116. doi:10.7324/JABB.2020.80117
   Google Scholar
• Bai G, Pan Y, Zhang Y, et al. Research advances of molecular docking and molecular dynamic simulation in recognizing interaction between muscle proteins and exogenous additives. Food Chem. 2023;429:136836. doi:10.1016/j.foodchem.2023.136836
   PubMed Web of Science ®Google Scholar
• Li X, Wei S, Niu S, et al. Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis. Comput Biol Med. 2022;144:105389. doi:10.1016/j.compbiomed.2022.105389
   PubMed Web of Science ®Google Scholar
• Li L, Liu S, Wang B, et al. An updated review on developing small molecule kinase inhibitors using computer-aided drug design approaches. Int J Mol Sci. 2023;24(18):13953. doi:10.3390/ijms241813953
   PubMed Web of Science ®Google Scholar
• Agu PC, Afiukwa CA, Orji OU, et al. Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep. 2023;13(1):13398. doi:10.1038/s41598-023-40160-2
   PubMed Web of Science ®Google Scholar
• Wei W, Wan H, Peng X, Zhou H, Lu Y, He Y. Antiviral effects of Ma Huang Tang against H1N1 influenza virus infection in vitro and in an ICR pneumonia mouse model. Biomed Pharmacother. 2018;102:1161–1175. doi:10.1016/j.biopha.2018.03.161
   PubMed Web of Science ®Google Scholar
• Utsunomiya H, Ichinose M, Ikeda K, et al. Inhibition by caffeic acid of the influenza A virus multiplication in vitro. Int J Mol Med. 2014;34(4):1020–1024. doi:10.3892/ijmm.2014.1859
   PubMed Web of Science ®Google Scholar
• Tan L, Jin H, Liu Y, et al. Main chemical constituents of Changyanning Tablets based on HPLC-Q-TOF-MS/MS. Chin Traditional Herbal Drugs. 2020;51(16):4124–4132.
   Google Scholar
• Abduljalil JM, Elfiky AA, Elgohary AM. Exploration of natural compounds against the human mpox virus DNA-dependent RNA polymerase in silico. J Infect Public Health. 2023;16(7):996–1003. doi:10.1016/j.jiph.2023.04.019
   PubMed Web of Science ®Google Scholar
• Wang S, Qiao J, Chen Y, Tian L, Sun X. Urolithin A inhibits enterovirus 71 replication and promotes autophagy and apoptosis of infected cells in vitro. Arch. Virol. 2022;167(10):1989–1997. doi:10.1007/s00705-022-05471-1
   PubMed Web of Science ®Google Scholar
• Wang C, Wang P, Chen X, Wang W, Jin Y. Saururus chinensis (Lour). Baill blocks enterovirus 71 infection by hijacking MEK1-ERK signaling pathway. Antiviral Res. 2015;119:47–56. doi:10.1016/j.antiviral.2015.04.009
   PubMed Web of Science ®Google Scholar
• Wu LL, Yang XB, Huang ZM, Liu HZ, Wu GX. In vivo and in vitro antiviral activity of hyperoside extracted from Abelmoschus manihot (L) medik. Acta Pharmacol Sin. 2007;28(3):404–409. doi:10.1111/j.1745-7254.2007.00510.x
   PubMed Web of Science ®Google Scholar
• Panchal R, Ghosh S, Mehla R, et al. Antiviral activity of rosmarinic acid against four serotypes of dengue virus. Curr Microbiol. 2022;79(7):203. doi:10.1007/s00284-022-02889-3
   PubMed Web of Science ®Google Scholar
• Shirasago Y, Inamori Y, Suzuki T, et al. Inhibition mechanisms of hepatitis C virus infection by caffeic acid and tannic acid. Biol Pharm Bull. 2019;42(5):770–777. doi:10.1248/bpb.b18-00970
   PubMed Web of Science ®Google Scholar
• Ding Y, Cao Z, Cao L, Ding G, Wang Z, Xiao W. Antiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) virus and its inhibition of neuraminidase. Sci Rep. 2017;10(7):45723. doi:10.1038/srep45723
   Google Scholar
• Lin WY, Yu YJ, Jinn TR. Evaluation of the virucidal effects of rosmarinic acid against enterovirus 71 infection via in vitro and in vivo study. Virol J. 2019;16(1):94. doi:10.1186/s12985-019-1203-z
   PubMed Web of Science ®Google Scholar
• Shi W, Hou X, Li X, et al. Differential gene expressions of the MAPK signaling pathway in enterovirus 71-infected rhabdomyosarcoma cells. Braz J Infect Dis. 2013;17(4):410–417. doi:10.1016/j.bjid.2012.11.009
   PubMed Web of Science ®Google Scholar
• Rivera-Torres J, San Jose E. Src tyrosine kinase inhibitors: new perspectives on their immune, antiviral, and senotherapeutic potential. Front Pharmacol. 2019;10:1011. doi:10.3389/fphar.2019.01011
   PubMed Web of Science ®Google Scholar
• Pan AN, Xu WW, Luo YL, et al. A novel system for predicting liver histopathology in patients with chronic hepatitis B. Medicine. 2017;96(14):e6465. doi:10.1097/MD.0000000000006465
   PubMed Web of Science ®Google Scholar
• Petersen M, Simmonds M. Rosmarinic acid. Phytochemistry. 2003;62(2):121–125. doi:10.1016/s0031-9422(02)00513-7
   PubMed Web of Science ®Google Scholar
• Hsieh CF, Jheng JR, Lin GH, et al. Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors. Emerg Microbes Infect. 2020;9(1):1194–1205. doi:10.1080/22221751.2020.1767512
   PubMed Web of Science ®Google Scholar
• Chen SG, Leu YL, Cheng ML, et al. Anti-enterovirus 71 activities of Melissa officinalis extract and its biologically active constituent rosmarinic acid. Sci Rep. 2017;7(1):12264. doi:10.1038/s41598-017-12388-2
   PubMedGoogle Scholar
• Chung YC, Hsieh FC, Lin YJ, et al. Magnesium lithospermate B and rosmarinic acid, two compounds present in Salvia miltiorrhiza, have potent antiviral activity against enterovirus 71 infections. Eur J Pharmacol. 2015;755:127–133. doi:10.1016/j.ejphar.2015.02.046
   PubMed Web of Science ®Google Scholar
• Weng JY, Chen XX, Wang XH, et al. Reducing lipid peroxidation attenuates stress-induced susceptibility to herpes simplex virus type 1. Acta Pharmacol Sin. 2023;44(9):1856–1866. doi:10.1038/s41401-023-01095-6
   PubMedGoogle Scholar
• Tsukamoto Y, Ikeda S, Uwai K, et al. Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction. PLoS One. 2018;13(5):e0197664. doi:10.1371/journal.pone.0197664
   PubMed Web of Science ®Google Scholar
• Jheng J-R, Hsieh C-F, Chang Y-H, et al. Rosmarinic acid interferes with influenza virus A entry and replication by decreasing GSK3β and phosphorylated AKT expression levels. J Microbiol Immunol Infect. 2022;55(4):598–610. doi:10.1016/j.jmii.2022.04.012
   PubMedGoogle Scholar
• Moschovou K, Antoniou M, Chontzopoulou E, et al. Exploring the binding effects of natural products and antihypertensive drugs on SARS-CoV-2: an in silico investigation of main protease and spike protein. Int J Mol Sci. 2023;24(21):15894. doi:10.3390/ijms242115894
   PubMed Web of Science ®Google Scholar